515 related articles for article (PubMed ID: 24334134)
1. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
5. Bone microarchitecture is more severely affected in patients on hemodialysis than in those receiving peritoneal dialysis.
Pelletier S; Vilayphiou N; Boutroy S; Bacchetta J; Sornay-Rendu E; Szulc P; Arkouche W; Guebre-Egziabher F; Fouque D; Chapurlat R
Kidney Int; 2012 Sep; 82(5):581-8. PubMed ID: 22718192
[TBL] [Abstract][Full Text] [Related]
6. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
7. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
Inaba M; Imanishi Y; Ueda M; Cho H; Tahara H; Ishimura E; Nishizawa Y; Yamakawa T; Okuno S
Clin Calcium; 2005 Sep; 15 Suppl 1():64-6; discussion 66-7. PubMed ID: 16272632
[TBL] [Abstract][Full Text] [Related]
9. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.
Wang WH; Chen LW; Lee CC; Sun CY; Shyu YC; Hsu HR; Chien RN; Wu IW
Biomed Res Int; 2017; 2017():7435657. PubMed ID: 28367447
[TBL] [Abstract][Full Text] [Related]
10. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
Ennis JL; Worcester EM; Coe FL; Sprague SM
J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors.
Erkal MZ; Wilde J; Bilgin Y; Akinci A; Demir E; Bödeker RH; Mann M; Bretzel RG; Stracke H; Holick MF
Osteoporos Int; 2006; 17(8):1133-40. PubMed ID: 16718398
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D, secondary hyperparathyroidism, and preeclampsia.
Scholl TO; Chen X; Stein TP
Am J Clin Nutr; 2013 Sep; 98(3):787-93. PubMed ID: 23885046
[TBL] [Abstract][Full Text] [Related]
15. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
[TBL] [Abstract][Full Text] [Related]
16. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
[TBL] [Abstract][Full Text] [Related]
18. [Vitamin D supply among healthy blood donors in Vas County, Hungary].
Virágh E; Horváth D; Lőcsei Z; Kovács L; Jáger R; Varga B; Kovács L G; Salamonné Toldy E
Orv Hetil; 2012 Oct; 153(41):1629-37. PubMed ID: 23045313
[TBL] [Abstract][Full Text] [Related]
19. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
[TBL] [Abstract][Full Text] [Related]
20. Posterior urethral valves: Metabolic consequences in a cohort of patients.
Sarhan O; Nakshabandi Z; Alghanbar M; Alotay A; Sherif I; Whitehead C; El-Husseini A
J Pediatr Urol; 2015 Aug; 11(4):216.e1-6. PubMed ID: 26096436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
